Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
8.62 USD | +0.70% | +0.23% | +7.48% |
23.04. | Bausch Health in "stärkerer Position" für Bausch + Lomb Ausschüttung, sagt RBC | MT |
23.04. | RBC gibt Vorschau auf Q1 von Bausch Health und senkt Ziel auf US$11 | MT |
Kurzporträt
Mitarbeiterzahl: 20 270
Umsatz nach Geschäftsbereich
CAD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Bausch + Lomb/International
47,3
%
| 4 905 | 46,4 % | 5 596 | 47,3 % | +14.07% |
Salix
25,7
%
| 2 721 | 25,7 % | 3 037 | 25,7 % | +11.61% |
International
12,2
%
| 1 286 | 12,2 % | 1 446 | 12,2 % | +12.38% |
Diversified
10,8
%
| 1 273 | 12,0 % | 1 273 | 10,8 % | -0.04% |
Solta Medical
4,0
%
| 391 | 3,7 % | 468 | 4,0 % | +19.92% |
Umsatz je Region
CAD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States and Puerto Rico
59,3
%
| 6 296 | 59,5 % | 7 010 | 59,3 % | +11.35% |
Other
11,5
%
| 1 155 | 10,9 % | 1 365 | 11,5 % | +18.17% |
China
5,0
%
| 538 | 5,1 % | 595 | 5,0 % | +10.70% |
Canada
4,2
%
| 457 | 4,3 % | 494 | 4,2 % | +8.10% |
Mexico
3,7
%
| 359 | 3,4 % | 435 | 3,7 % | +20.95% |
Poland
3,6
%
| 362 | 3,4 % | 431 | 3,6 % | +18.96% |
France
2,4
%
| 264 | 2,5 % | 289 | 2,4 % | +9.29% |
Japan
2,2
%
| 260 | 2,5 % | 262 | 2,2 % | +0.56% |
Germany
1,7
%
| 191 | 1,8 % | 205 | 1,7 % | +7.20% |
Russia
1,7
%
| 236 | 2,2 % | 200 | 1,7 % | -15.23% |
United Kingdom
1,4
%
| 150 | 1,4 % | 169 | 1,4 % | +12.69% |
South Korea
1,1
%
| 100 | 0,9 % | 126 | 1,1 % | +25.22% |
Spain
1,1
%
| 109 | 1,0 % | 124 | 1,1 % | +13.55% |
Italy
1,0
%
| 99 | 0,9 % | 116 | 1,0 % | +17.32% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24.05.22 |
Chief Operating Officer | - | - | |
Tage Ramakrishna
CTO | Chief Tech/Sci/R&D Officer | 49 | 01.01.11 |
Investor Relations Contact | - | 19.06.17 | |
Human Resources Officer | - | 01.01.19 | |
Jeff Hartness
LAW | General Counsel | - | - |
Dennis Asharin
PRN | Corporate Officer/Principal | - | 01.01.07 |
Treasurer | 48 | - | |
Corporate Officer/Principal | 59 | 08.08.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01.08.08 |
John Paulson
CHM | Chairman | 68 | 01.06.17 |
Steven Miller
BRD | Director/Board Member | 35 | 17.03.21 |
Richard Mulligan
BRD | Director/Board Member | 69 | 06.05.22 |
Brett Icahn
BRD | Director/Board Member | 44 | 17.03.21 |
Russel Robertson
BRD | Director/Board Member | 76 | 14.06.16 |
Thomas Ross
BRD | Director/Board Member | 73 | 08.03.16 |
Sarah Kavanagh
BRD | Director/Board Member | 67 | 22.07.16 |
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
Amy Wechsler
BRD | Director/Board Member | 54 | 14.06.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 366 672 723 | 358 095 255 ( 97,66 %) | 0 | 97,66 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
BAUSCH + LOMB CORPORATION 88,45% | 310 449 643 | 88,45% | 5 370 778 824 $ |
Unternehmenskontakt
Bausch Health Cos., Inc.
2150 St. Elzéar Boulevard West
H7L 4A8, Laval
+514 744 6792
http://www.bauschhealth.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Bausch & Lomb India Pvt Ltd.
Bausch & Lomb India Pvt Ltd. Electronic ComponentsElectronic Technology Part of Bausch Health Cos., Inc., Bausch & Lomb India Pvt Ltd. is a private company that specializes in providing soft contact lenses and lens care products. The company was founded in 2000. The company is based in Gurgaon, India. The Indian company's main focus is to help people see better and live better by providing soft contact lenses that are specifically shaped to focus light into the retina of the eye. Additionally, Bausch + Lomb offers a complete line of soft contact lens care products designed to make the lens wearing experience healthy and comfortable. |
Electronic Components
|
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+7.48% | 3.14 Mrd. | |
+24.17% | 562 Mrd. | |
-6.33% | 358 Mrd. | |
+19.90% | 322 Mrd. | |
+7.95% | 297 Mrd. | |
+13.45% | 219 Mrd. | |
+6.04% | 199 Mrd. | |
-10.51% | 196 Mrd. | |
-12.26% | 149 Mrd. | |
-6.47% | 146 Mrd. |
- Börse
- Aktien
- A2JQ1X Aktie
- Unternehmen Bausch Health Companies Inc.